Give feedback

We need your feedback & comments

The MACRA required us to ask for your feedback.

2023 MIPS cost performance category resources

  • 2023 Cost Measure Information Forms (ZIP) detail the cost measure methodology for each of the 23 episode-based cost measures and the revised Medicare Spending Per Beneficiary (MSPB) Clinician and Total Per Capita Cost (TPCC) measures that are in use for the cost performance category in 2023.
  • 2023 Cost Measure Codes Lists (ZIP) detail the cost measure codes list for each of the 23 episode-based cost measures and the revised MSPB Clinician and TPCC measures that are in use for the cost performance category in 2023.
  • 2023 MIPS Summary of Cost Measures (PDF) provides a summary of cost measures in use for MIPS in 2023 as well as measures under development.

Wave 5 cost measures field testing

From January 17 to February 14, 2023, we are field testing 5 newly developed Wave 5 episode-based cost measures for consideration in MIPS. During field testing, eligible clinicians and clinician groups ere able to download their Field Test Reports from the Quality Payment Program website and give feedback on the draft measure specifications. These reports are for field testing only, and don’t affect any scoring or payment adjustments.

Learn more:

You can also review the measure specifications, measure testing forms, and supplemental documents for the 5 episode-based cost measures:

Wave 5 cost measure development (2022-2023)

  • Wave 5 Public Comment Summary Report (PDF) describes input received during the Wave 5 pubic comment period on candidate measure areas, which was held from February 18, 2022 to April 1, 2022, and provides brief responses to feedback.
  • Summary of Wave 5 Workgroup Meeting (ZIP) contains a high-level summary of each of the measure-specific workgroup meetings held in in 7/2022. Workgroup members gave detailed input on each component of the cost measure, including:
    • Defining the episode group
    • Addressing patient sub-populations for meaningful clinical comparison
    • Assigning services to the episode group
  • Summary of Wave 5 Service Assignment and Refinement (SAR) Workgroup Meetings (ZIP) contains a high-level summary of each of the measure-specific workgroup meetings held in 9/2022 and 10/2022. Workgroup members gave input on:
    • Assigning services to the episode group
    • Potential refinements to the measure specifications before national field testing
  • Wave 5 Measure-Specific Workgroup Composition List (PDF) is the list of members of the measure-specific workgroups that met in 7/2022 to give detailed clinical input on the measure specifications for the 3 episode groups being developed in Wave 5.

Wave 1 cost measure comprehensive reevaluation (2022-2023)

From February 1 to February 28, 2023, we are requesting input on potential revisions to 3 episode-based cost measures undergoing comprehensive reevaluation before consideration of their use in the Merit-Based Incentive Payment System (MIPS):

  • Cataract Removal with Intraocular Lens (IOL) Implantation (currently Routine Cataract Removal with Intraocular Lens (IOL) Implantation)
  • Inpatient Percutaneous Coronary Intervention (PCI) (currently ST-Elevation Myocardial Infarction [STEMI] with PCI)
  • Respiratory Infection Hospitalization (currently Simple Pneumonia with Hospitalization)

Note: These potential revisions would not take effect in performance years 2023 or 2024. Any revisions would go through the pre-rulemaking and rulemaking process before potential use in performance year 2025. The current version of the measures remains in use in MIPS until any revisions are finalized.

You may provide feedback via online survey now through 11:59 PM ET on February 28, 2023, on the draft updates to measure specifications. Please feel free to share this message with anyone who may be interested in these activities. Click on the link below to access the survey:

You can also review the measure specifications and supplemental documents:

Wave 4 cost measure development and refinement (2021-2022)

Chronic Kidney Disease/End-Stage Renal Disease (CKD/ESRD) cost measure development (2021-2022)

Learn about the cost measures & the development process

Content experts and other interested members of the public have had many opportunities to provide input throughout the process. Learn more about the MACRA cost measure development process from:

Please see below to learn about the cost measures developed in Wave 2:

Please see below to learn more about the cost measures developed in Wave 3:

Learn about the Care Episode & Patient Condition Codes

Prior feedback requests:

How can I learn about the Patient Relationship Categories & Codes?

  • Read more (PDF), based on your comments, about patient relationship categories and how we may use Current Procedural Terminology (CPT) Modifiers for reporting patient relationship codes.
  • View slides, transcripts, recordings and FAQs from the 2/21/18 and the 10/17/18 Patient Relationship Categories & Codes webinars.  
Page Last Modified:
03/16/2023 03:28 PM